Find out what the numbers really say — before the market does
Analyze now
News Sentiment
Are today's headlines a buy signal or a red flag?
Analyze now
Buy / Hold / Sell
Should you Buy, Hold, or Sell? Get the AI verdict now.
Analyze now
Risk Assessment
Uncover hidden risks before they hit your portfolio.
Analyze now
Fair Value
Is this stock cheap, fairly priced, or overvalued?
Analyze now
Latest AI Analyses of ALLERGY THER. PLC LS-,001
No Price
Closing Price XLON 01.05.2026:
10,27 GBX
01.05.2026 15:02
Current Prices from ALLERGY THER. PLC LS-,001
Exchange
Ticker
Currency
Last Trade
Price
Daily Change
London
AGY.L
GBX
01.05.2026 15:02
10,27 GBX
-0,68 GBX
-6,21 %
UTC
AGYTF
USD
30.04.2026 20:00
0,11 USD
0,00 USD
Share Float & Liquidity
Free Float6,58 %
Shares Float331,58 M
Shares Outstanding5,04 B
Company Profile for ALLERGY THER. PLC LS-,001 Share
Allergy Therapeutics plc, a biotechnology company, engages in the research and development of allergy treatments. The company sells injectable and sublingual allergen-specific immunotherapies; and offers prescription for the treatment of pollen-related allergies particularly to grasses, weeds, and trees, as well as diagnostics. Its products include Pollinex Quattro, Oralvac, Venomil, ImmunoBON, Synbiotics, Acarovac Plus, Penicillin diagnostics, Pollinex, and VLP Peanut. The company also develops allergy vaccines for trees, grass, house dust mite, and pets with fur/hair, as well as peanut allergy vaccines. It operates in Central Europe, Southern Europe, the United Kingdom, and internationally. Allergy Therapeutics plc was incorporated in 2004 and is headquartered in Worthing, the United Kingdom.
